|
V.BTI.H
|
Does it make any difference, pof? Rathjen and Ladenburg Thalmann may have...
|
|
V.BTI.H
|
Bioasis, with a market cap tonight of CDN $11.5 million, is being bought by a...
|
|
V.BTI.H
|
During February of 2019 I was on the phone with shareholders for 12 hours a...
|
|
V.BTI.H
|
Don't be so quick to discount xB3, narmac. I think it's all about xB3...
|
|
V.BTI.H
|
Why do I care, unclepirman asks. I now have almost 1.7 million reasons for...
|
|
V.BTI.H
|
The Midatech guy is talking now. eom
|
|
V.BTI.H
|
I don't think it's likely that the regular shareholders can vote this...
|
|
V.BTI.H
|
Does Bioasis have a verbal agreement with Ellipses Pharma for xB3-001? Is it...
|
|
V.BTI.H
|
Javier Cortes, M.D., Ph.D., is a member of the Bioasis Medical Advisory Board...
|
|
V.BTI.H
|
In the June roadshow, Dr. Deborah Rathjen handed out a corporate information...
|
|
V.BTI.H
|
Not a chance! EOM
|
|
V.BTI.H
|
Just looking at who gets what upon completion. Look at how much certain...
|
|
V.BTI.H
|
Nope, doesn't look too good. We need the Bioasis press release, maybe...
|
|
V.BTI.H
|
Watch and learn, GFF. jd
|
|
V.BTI.H
|
Sounds like you're the one make a last gasp of relevance, Finallytherock,...
|
|
V.BTI.H
|
Yeah, funny one, craighenry. Did GD send you that link? If so, why can't...
|
|
V.BTI.H
|
Finallytherock, Bioasis is being sold for shares, which means that the blue...
|
|
V.BTI.H
|
Yep, you could be right, GFF. That would work for me. jd
|
|
V.BTI.H
|
Midatech taking over Bioasis. Midatech has less than 4 million shares...
|
|
V.BTI.H
|
Giddy up, poof, giddy up. Next week it'll be, "Whoa, poof, whoa...
|